Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9B1Y3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.353 |
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.526 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.353 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.524 |
CLV_PCSK_PC7_1 | 56 | 62 | PF00082 | 0.518 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.405 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.441 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.614 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.664 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.811 |
LIG_14-3-3_CanoR_1 | 29 | 33 | PF00244 | 0.621 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.447 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.307 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.721 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.435 |
LIG_SH2_GRB2like | 117 | 120 | PF00017 | 0.732 |
LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.615 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.549 |
LIG_SH3_3 | 101 | 107 | PF00018 | 0.634 |
LIG_SUMO_SIM_anti_2 | 3 | 12 | PF11976 | 0.346 |
LIG_SUMO_SIM_anti_2 | 73 | 78 | PF11976 | 0.577 |
LIG_TRAF2_1 | 132 | 135 | PF00917 | 0.671 |
LIG_TYR_ITIM | 15 | 20 | PF00017 | 0.321 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.724 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.758 |
MOD_N-GLC_2 | 100 | 102 | PF02516 | 0.367 |
MOD_PKA_1 | 59 | 65 | PF00069 | 0.661 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.663 |
MOD_PKA_2 | 55 | 61 | PF00069 | 0.717 |
MOD_Plk_1 | 113 | 119 | PF00069 | 0.647 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.689 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.349 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.813 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.321 |
TRG_ER_diArg_1 | 59 | 61 | PF00400 | 0.721 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P382 | Leptomonas seymouri | 35% | 100% |
A0A3S5H7Q1 | Leishmania donovani | 84% | 100% |
E9AEF5 | Leishmania major | 88% | 100% |
E9AHL4 | Leishmania infantum | 84% | 100% |
E9AIU5 | Leishmania braziliensis | 72% | 100% |